Taha, Zaid ;
Arulanandam, Rozanne ;
Maznyi, Glib...
Taha , Z , Arulanandam , R , Maznyi , G , Godbout , E , Carter-Timofte , M E , Kurmasheva , N , Reinert , L S , Chen , A , Crupi , M J F , Boulton , S , Laroche , G , Phan , A , Rezaei , R , Alluqmani , N , Jirovec , A , Acal , A , Brown , E E F , Singaravelu , R , Petryk , J , Idorn , M , Potts , K G , Todesco , H , John , C , Mahoney , D J , Ilkow , C S , Giguère , P , Alain , T , Côté , M , Paludan , S R , Olagnier , D , Bell , J C , Azad , T & Diallo , J-S 2022 , ' Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen ' , Molecular Therapy , vol. 30 , no. 9 , pp. 2998-3016 . https://doi.org/10.1016/j.ymthe.2022.04.025.
,
2022
